• Product NameCevimeline hydrochloride hemihydrate
• Brief DescriptionInhibitors
• Purification99.50%
• Biological ActivityCevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome.
• Target NameAChR antagonist
• CAS No. 153504-70-2
• Calculated MW 489.55
• Formulation C20H38Cl2N2O3S2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:CC1O[C@]2(CN3CCC2CC3)CS1.CC1O[C@]2(CN3CCC2CC3)CS1.O.Cl.Cl
  Pathways:Neuroscience
  Receptor:mAChR
  Boling pt:
  Melting pt:
  Solubility:DMSO: 10 mM
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Washio Takuo, et al. Arzneimittel-Forschung (2003), 53(2), 80-86.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting